BORTDEXADARA Regimen
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
SYNOPSIS
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Multiple Myeloma in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 10 (2011)
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma | Future Oncology
Hematology treatment policies: Plasma cell neoplasms - Sunnybrook Hospital
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study - The Lancet Oncology
Pharmaceuticals | Free Full-Text | Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
VAD and similar alternate regimens | Download Table
CLINICAL TRIAL FACT SHEET
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
